1. Home
  2. CTSO vs WPRT Comparison

CTSO vs WPRT Comparison

Compare CTSO & WPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • WPRT
  • Stock Information
  • Founded
  • CTSO 1997
  • WPRT 1995
  • Country
  • CTSO United States
  • WPRT Canada
  • Employees
  • CTSO N/A
  • WPRT N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • WPRT Industrial Machinery/Components
  • Sector
  • CTSO Health Care
  • WPRT Industrials
  • Exchange
  • CTSO Nasdaq
  • WPRT Nasdaq
  • Market Cap
  • CTSO 65.7M
  • WPRT 69.7M
  • IPO Year
  • CTSO N/A
  • WPRT 1995
  • Fundamental
  • Price
  • CTSO $0.95
  • WPRT $3.77
  • Analyst Decision
  • CTSO Buy
  • WPRT Buy
  • Analyst Count
  • CTSO 2
  • WPRT 3
  • Target Price
  • CTSO $5.50
  • WPRT $6.33
  • AVG Volume (30 Days)
  • CTSO 93.3K
  • WPRT 29.0K
  • Earning Date
  • CTSO 08-07-2025
  • WPRT 08-11-2025
  • Dividend Yield
  • CTSO N/A
  • WPRT N/A
  • EPS Growth
  • CTSO N/A
  • WPRT N/A
  • EPS
  • CTSO N/A
  • WPRT N/A
  • Revenue
  • CTSO $35,332,238.00
  • WPRT $295,680,000.00
  • Revenue This Year
  • CTSO $11.15
  • WPRT N/A
  • Revenue Next Year
  • CTSO $21.39
  • WPRT N/A
  • P/E Ratio
  • CTSO N/A
  • WPRT N/A
  • Revenue Growth
  • CTSO 15.37
  • WPRT N/A
  • 52 Week Low
  • CTSO $0.71
  • WPRT $2.50
  • 52 Week High
  • CTSO $1.61
  • WPRT $6.20
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 39.94
  • WPRT 67.00
  • Support Level
  • CTSO $0.91
  • WPRT $3.06
  • Resistance Level
  • CTSO $1.06
  • WPRT $4.10
  • Average True Range (ATR)
  • CTSO 0.06
  • WPRT 0.20
  • MACD
  • CTSO -0.01
  • WPRT -0.01
  • Stochastic Oscillator
  • CTSO 13.97
  • WPRT 75.32

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.

Share on Social Networks: